The Impact of Branched-Chain Amino Acid Metabolism on Limb Dysfunction in PAD



Status:Recruiting
Conditions:Peripheral Vascular Disease
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:50 - Any
Updated:6/9/2018
Start Date:May 22, 2018
End Date:March 2022
Contact:Emily Banks, BS
Email:emily.m.shardelow@vumc.org
Phone:+1 (615) 875-8949

Use our guide to learn which trials are right for you!

The Impact of Branched-Chain Amino Acid Metabolism on Limb Dysfunction in PAD (MicroPAD)

Test the theory that abnormalities in the large blood vessels that deliver blood to your leg
and the very small blood vessels in your leg's muscles (invisible to the eye) work together
to worsen your leg function and walking.


Healthy volunteers

Inclusion criteria

- Male or female, age ≥ 50 years old

- Non-smoker

Exclusion criteria

- Presence of peripheral artery disease

- History of a heart attack or stroke

- Diabetes

- Active cancer

- Severe renal disease (CrCl < 60)

- Severe liver disease

- Active rheumatological diseases

PAD patients

Inclusion criteria

- Male or female, age 50 years or older

- Atherosclerotic PAD, ABI ≤0.85

- Willing to comply with protocol, attend follow-up appointments, complete all study
assessments, and provide informed consent

Exclusion criteria

- Presence of a femoral, popliteal or tibial aneurysm of the index limb

- Life expectancy less than 2 years

- A vascular disease prognosis that includes an anticipated above ankle amputation on
index limb within 4 weeks of index procedure

- Renal dysfunction defined as MDRD eGFR ≤ 20ml/min/173 m2 at the time of screening

- Currently on dialysis or history of a renal transplant

- Cirrhosis or active hepatitis

- A documented hypercoagulable state

- Myocardial infarction within 6 months

- Stroke within 6 months

- Nonatherosclerotic occlusive disease of the lower extremity

- Any prior infrainguinal revascularization on index limb

- Current immunosuppressive medication, chemotherapy or radiation therapy

- Absolute contraindication to iodinated contrast

- Inability to have an MRI

- Exercise limitation aside from that due to PAD (i.e. COPD, degenerative joint disease,
etc.)

- Women who are pregnant

- Women who are nursing
We found this trial at
1
site
1211 Medical Center Dr
Nashville, Tennessee 37232
(615) 322-5000
Principal Investigator: Joshua Beckman, MD
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
?
mi
from
Nashville, TN
Click here to add this to my saved trials